Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 23;9(6):e100618.
doi: 10.1371/journal.pone.0100618. eCollection 2014.

Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure

Satoshi Abe  1 , Akiomi Yoshihisa  2 , Mai Takiguchi  1 , Takeshi Shimizu  1 , Yuichi Nakamura  1 , Hiroyuki Yamauchi  1 , Shoji Iwaya  1 , Takashi Owada  1 , Makiko Miyata  1 , Takamasa Sato  1 , Satoshi Suzuki  2 , Masayoshi Oikawa  1 , Atsushi Kobayashi  1 , Takayoshi Yamaki  1 , Koichi Sugimoto  1 , Hiroyuki Kunii  1 , Kazuhiko Nakazato  1 , Hitoshi Suzuki  1 , Shu-ichi Saitoh  1 , Yasuchika Takeishi  2
Affiliations

Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure

Satoshi Abe et al. PLoS One. .

Abstract

Aims: Liver dysfunction due to heart failure (HF) is often referred to as cardiac or congestive hepatopathy. The composite Model for End-Stage Liver Disease excluding INR (MELD-XI) is a robust scoring system of liver function, and a high score is associated with poor prognosis in advanced HF patients with a heart transplantation and/or ventricular assist device. However, the impact of MELD-XI on the prognosis of HF patients in general remains unclear.

Methods and results: We retrospectively analyzed 562 patients who were admitted to our hospital for the treatment of decompensated HF. A MELD-XI score was graded, and patients were divided into two groups based on the median value of MELD-XI score: Group L (MELD-XI <10, n = 289) and Group H (MELD-XI ≥10, n = 273). We compared all-cause mortality and echocardiographic findings between the two groups. In the follow-up period (mean 471 days), 104 deaths (62 cardiac deaths and 42 non-cardiac deaths) were observed. The event (cardiac death, non-cardiac death, all-cause death)-free rate was significantly higher in group L than in group H (logrank P<0.05, respectively). In the Cox proportional hazard analysis, a high MELD-XI score was found to be an independent predictor of cardiac deaths and all-cause mortality in HF patients. Regarding echocardiographic parameters, right atrial and ventricular areas, inferior vena cava diameter, and systolic pulmonary artery pressure were higher in group H than in group L (P<0.05, respectively).

Conclusions: The MELD-XI scoring system, a marker of liver function, can identify high-risk patients with right heart volume overload, higher pulmonary arterial pressure and multiple organ failure associated with HF.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Kaplan-Meier analysis for A) cardiac death, B) non-cardiac death, and C) all-cause mortality between group L and group H.
See this image and copyright information in PMC

References

    1. Kim MS, Kato TS, Farr M, Wu C, Givens RC, et al. (2013) Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol 61: 2253–2261. - PMC - PubMed
    1. Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, et al. (2012) Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest 42: 153–163. - PubMed
    1. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, et al. (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 11: 170–177. - PMC - PubMed
    1. Batin P, Wickens M, McEntegart D, Fullwood L, Cowley AJ (1995) The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 16: 1613–1618. - PubMed
    1. Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, et al. (2008) Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 72: 364–369. - PubMed

Publication types